Sandbox Listeriosis medical therapy

Jump to navigation Jump to search

Listeriosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Listeriosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Screening

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox Listeriosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox Listeriosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox Listeriosis medical therapy

CDC on Sandbox Listeriosis medical therapy

Sandbox Listeriosis medical therapy in the news

Blogs on Sandbox Listeriosis medical therapy

Directions to Hospitals Treating Listeriosis

Risk calculators and risk factors for Sandbox Listeriosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Ampicillin, with or without gentamicin, is considered the drug of choice for listeriosis. Patients intolerant of penicillins may be managed with trimethoprim-sulfamethoxazole alternatively. Suggested minimum duration of therapy depends on clinical manifestations: bacteremia should be treated for 2 weeks, meningitis for 3 weeks, endocarditis for 4 to 6 weeks, and brain abscess or rhomboencephalitis for at least 6 weeks.

Principles of Therapy

  • Meningitis is the most common clinical manifestation, and antibiotics that penetrate well into the CSF should be chosen.

Medical Therapy for Listeria monocytogenes Adapted from Clin Infect Dis. 1997;24(1):1-9.,[3] Clin Infect Dis. 2005;40(9):1327-32.,[4] and Clin Infect Dis. 2004;39(9):1267-84.[5]

▸ Click on the following categories to expand treatment regimens.

L. monocytogenes Infections

  ▸  Bacteremia

  ▸  Brain Abscess

  ▸  Endocarditis

  ▸  Gastroenteritis

  ▸  Meningitis

  ▸  Rhombencephalitis

Listeria monocytogenes, Bacteremia
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 2 mg/kg IV load, then 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 10—20 mg/kg/day IV q6—12h (TMP component)
OR
Meropenem 2 g IV q8h
Minimum duration of therapy: 2 weeks
Listeria monocytogenes, Brain Abscess
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 2 mg/kg IV load, then 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 10—20 mg/kg/day IV q6—12h (TMP component)
OR
Meropenem 2 g IV q8h
Minimum duration of therapy: 6 weeks
Listeria monocytogenes, Endocarditis§
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 2 mg/kg IV load, then 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 10—20 mg/kg/day IV q6—12h (TMP component)
OR
Meropenem 2 g IV q8h
§ Minimum duration of therapy: 4—6 weeks
Listeria monocytogenes, Gastroenteritis
Preferred Regimen
▸ Antimicrobial therapy is not warranted in most cases.
Alternative Regimen
(For Outbreaks and Invasive Diseases)
Ampicillin 500 mg PO q6h x 5 days
OR
TMP/SMZ 160/800 mg PO q12h x 5 days
Listeria monocytogenes, Meningitis
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 2 mg/kg IV load, then 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 10—20 mg/kg/day IV q6—12h (TMP component)
OR
Meropenem 2 g IV q8h
Minimum duration of therapy: 3 weeks
Listeria monocytogenes, Rhombencephalitis
Preferred Regimen
Ampicillin 2 g IV q4h
OR
Penicillin G 4 MU IV q4h
PLUS
Gentamicin 2 mg/kg IV load, then 1.7 mg/kg IV q8h
Alternative Regimen
TMP/SMZ 10—20 mg/kg/day IV q6—12h (TMP component)
OR
Meropenem 2 g IV q8h
Minimum duration of therapy: 6 weeks

References

  1. Stamm, AM.; Dismukes, WE.; Simmons, BP.; Cobbs, CG.; Elliott, A.; Budrich, P.; Harmon, J. "Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases". Rev Infect Dis. 4 (3): 665–82. PMID 6750737.
  2. Gellin, BG.; Broome, CV. (1989). "Listeriosis". JAMA. 261 (9): 1313–20. PMID 2492614. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Lorber, B. (1997). "Listeriosis". Clin Infect Dis. 24 (1): 1–9, quiz 10-1. PMID 8994747. Unknown parameter |month= ignored (help)
  4. Ooi, ST.; Lorber, B. (2005). "Gastroenteritis due to Listeria monocytogenes". Clin Infect Dis. 40 (9): 1327–32. doi:10.1086/429324. PMID 15825036. Unknown parameter |month= ignored (help)
  5. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM et al. (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 (9):1267-84. DOI:10.1086/425368 PMID: [1]